Search results

Lutetium-177 used for advanced prostate cancer

This week, ANSTO hosted the 10th annual Regional Advisory Safety Committee for research reactors in Asia pacific (RASCAP). This a joint IAEA-Asian Nuclear Safety Network (ANSN) supported forum to foster networking and regional cooperation, and for facilitating use of competencies in the region to cover specific safety issues in research reactors.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.

Bushfires in proximity to ANSTO during the 2018 bushfires.

ANSTO's facilities in Sydney include access to neutron beam instruments, X-ray and infrared instruments, biological and chemical deuteration, accelerators, and an array of other capabilities and techniques.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.